The chronic fatigue syndrome - An update

Acta Neurologica Scandinavica

Volumn 115, Issue SUPPL.187, 2007, Pages 7-14

  Wyller, Vegard Bruun ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Chronic fatigue syndrome; Diagnosis; Epidemiology; Myalgic encephalomyelitis; Pathophysiology; Prognosis; Review; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; GROWTH HORMONE; IMMUNOGLOBULIN; MINERALOCORTICOID;

CARDIOVASCULAR SYSTEM; CHRONIC FATIGUE SYNDROME; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL PRACTICE; COGNITION; COGNITIVE THERAPY; CONFERENCE PAPER; CONVALESCENCE; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DISEASE SEVERITY; ENDOCRINE SYSTEM; EXERCISE; FATIGUE; FUNCTIONAL DISEASE; GENETIC POLYMORPHISM; GROUPS BY AGE; HOMEOSTASIS; HUMAN; IMMUNE DEFICIENCY; INFECTION; KINESIOTHERAPY; KNOWLEDGE; MEDICAL RESEARCH; MENTAL STRESS; MUSCLE FUNCTION; PATHOPHYSIOLOGY; PERSONALITY; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; REST; RISK FACTOR; SEX RATIO; SKELETAL MUSCLE; SOCIAL PSYCHOLOGY; STANDARDIZATION; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNITED STATES; CENTRAL NERVOUS SYSTEM; EPIDEMIOLOGY; IMMUNOLOGY; METABOLISM; PSYCHOLOGICAL ASPECT; REVIEW; STANDARD; VIRUS INFECTION;

CAUSALITY; CENTRAL NERVOUS SYSTEM; COGNITIVE THERAPY; EXERCISE THERAPY; FATIGUE SYNDROME, CHRONIC; HUMANS; MUSCLE, SKELETAL; STRESS, PSYCHOLOGICAL; VIRUS DISEASES;

EID: 34047204998     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00840.x     Document Type: Conference Paper

References (77)

1. AFARI N, BUCHWALD D. Chronic fatigue syndrome - a review. Am J Psychiatry 2003;160:221-36.
2. PRINS JB, VAN DER MEER JW, BLEIJENBERG G. Chronic fatigue syndrome. Lancet 2006;367:346-55.
3. FUKUDA K, STRAUS SE, HICKIE I, SHARPE MC, DOBBINS JG, KOMARO A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-9.
4. SHARPE MC. A report - chronic fatigue syndrome: guidelines for research. J R Soc Med 1991;84:118-21.
5. LLOYD AR, HICKIE I, BOUGHTON CR, SPENCER O, WAKEFIELD D. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust 1990;153:522-8.
6. CARRUTHERS BM, JAIN AK, MEIRLEIR KLD, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 2003;11:7-36.
7. WESSELY S. Old wine in new bottles: neurasthenia and 'ME'. Psychol Med 1990;20:35-53.
8. BINDER LM, CAMPBELL KA. Medically unexplained symptoms and neuropsychological assessment. J Clin Exp Neuropsychol 2004;26:369- 92.
9. JASON LA, RICHMAN JA, RADEMAKER AW, et al. A community-based study of chronic fatigue syndrome. Arch Intern Med 1999;159:2129-37.
10. REYES M, NISENBAUM R, HOAGLIN DC, et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med 2003;163:1530-6.
11. WESSELY S, CHALDER T, HIRSCH S, WALLACE P, WRIGHT D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997;87:1449-55.
12. FARMER A. Prevalence of chronic disabling fatigue in children and adolescents. Br J Psychiatry 2004;184:477-81.
13. SKAPINAKIS P, LEWIS G, MAVREAS V. Cross-cultural differences in the epidemiology of unexplained fatigue syndromes in primary care. Br J Psychiatry 2003;182:205-9.
14. SHEPHERD C. Living with ME: the chronic/post-viral fatigue syndrome. London: Vermilion, 1998.
15. WESSELY S. History of postiviral fatigue syndrome. Br Med Bull 1991;47:919-41.
16. JENKINS R. Epidemiology: lessons from the past. Br Med Bull 1991;47:952-65.
17. SODERLUND A, SKOGE AM, MALTERUD K. "I could not lift my arm holding the fork...": living with chronic fatigue syndrome. Scand J Prim Health Care 2000;18:165-9.
18. FEDER HM, DWORKIN PH, ORKIN C. Outcome of 48 pediatric patients with chronic fatigue. A clinical experience. Arch Fam Med 1994;3:1049-55.
19. DIAGNOSTISERING OG BEHANDLING AV KRONISK UTMATTELSESSYNDROM/ myalgisk encefalopati (CFS/ME). Rapport fra Kunnskapssenteret nr 9 - 2006. Oslo: Nasjonalt kunnskapssenter for helsetjenesten, 2006.
20. A REPORT OF THE CFS/ME Working Group: report to the Chief Medical Officer of an independent working group. London: Department of Health, 2002.
21. ROYAL COLLEGE OF PAEDIATRICS AND CHILD HEALTH. Evidence based guidelines for the management of CFS/ME (chronic fatigue syndrome/myalgic encephalopathy) in children and young adults. London: Royal College of Paediatrics and Child Health, 2004.
22. NETTLETON S. 'I just want permission to be ill': towards a sociology of medically unexplained symptoms. Soc Sci Med 2006;62:1167-78.
23. ASBRING P, NARVANEN AL. Ideal versus reality: physicians perspectives on patients with chronic fatigue syndrome (CFS) and fibromyalgia. Soc Sci Med 2003;57:711-20.
24. GOLDSTEIN DS. The autonomic nervous system in health and disease. New York: Marcel Dekker, 2001.
25. WESSELY S. Chronic fatigue: symptom and syndrome. Ann Intern Med 2001;134:838-43.
26. CHO HJ, SKOWERA A, CLEARE A, WESSELY S. Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology. Curr Opin Psychiatry 2006;19:67-73.
27. SMITH AK, WHITE PD, ASLAKSON E, VOLLMER-CONNA U, RAJEEVAN MS. Pyolymorphism in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 2006;7:387-94.
28. GOERTZEL BN, PENNACHIN C, COELHO LS, GURBAXANI B, MALONEY EM, Jones JF. Combination of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics 2006;7:475-83.
29. CANDY B, CHALDER T, CLEARE AJ, WESSELY S, WHITE PD, HOTOPF M. Recovery from infectious mononucleosis: a case for more than symptomatic therapy? Br J Gen Pract 2002;52:844-51.
30. CHIA JKS. The role of enterovirus in chronic fatigue syndrome. J Clin Pathol 2005;58:1126-32.
31. WESSELY S, CHALDER T, HIRSH S, et al. Postinfectious fatigue: prospective cohort study in primary care. Lancet 1995;345:1333-8.
32. GOW JW, BEHAN WM, CLEMENTS GB, WOODALL C, RIDING M, BEHAN PO. Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. BMJ 1991;302:692-6.
33. LYALL M, PEAKMAN M, WESSELY S. A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J Psychosom Res 2003;55:79-90.
34. TOMODA A, JHODOI T, MIIKE T. Chronic fatigue syndrome and abnormal biological rhythms in school children. J Chronic Fatigue Syndr 2001;8:29-36.
35. CANNON JG, ANGEL JB, BALL RW, ABAD LW, FAGIOLI L, KOMARO AL. Acute phase response and cytokine secretion in chronic fatigue syndrome. J Clin Immunol 1999;19:414-21.
36. DEMEIRLEIR K, BISBAL C, CAMPINE I, et al. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med 2000;108:99-105.
37. FULCHER KY, WHITE PD. Strength and physiological response to exercise in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 2000;69:302-7.
38. SCHILLINGS ML, KALKMAN JS, VAN DER WERF SP, VAN ENGELEN BG, BLEIJENBERG G, ZWARTS MJ. Diminished central activation during maximal voluntary contraction in chronic fatigue syndrome. Clin Neurophysiol 2004;115:2518- 24.
39. SIEMIONOW V, FANG Y, CALABRESE L, SAHGAL V, YUE GH. Altered central nervous system signal during motor performance in chronic fatigue syndrome. Clin Neurophysiol 2004;115:2372-81.
40. STARR A, SCALISE A, GORDON R, MICHALEWSKI HJ, CARAMIA MD. Motor cortex excitability in chronic fatigue syndrome. J Clin Neurophysiol 2000;111:2025-31.
41. DE LANGE FP, KALKMAN JS, BLEIJENBERG G, HAQOORT P, VAN DER MEER JW, TONI I. Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage 2005;26:777-81.
42. DE LANGE FP, KALKMAN JS, BLEIJENBERG G, et al. Neural correlates of the chronic fatigue syndrome - an fMRI study. Brain 2004;127:1948-57.
43. YOSHIUCHI K, FARKAS J, NATELSON BH. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin Physiol Funct Imaging 2006;26:83-6.
44. COSTA DC, TANNOCK C, BROSTO J. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 1995;88:767-73.
45. LEWIS DH, MAYBERG HS, FISHER ME, et al. Monozygotic twins discordant for chronic fatigue syndrome: regional cerebral blood flow SPECT. Radiology 2001;219:766-73.
46. TIRELLI U, CHIERICHETTI F, TAVIO M, et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 1998;28:54S-8S.
47. SIESSMEIER T, NIX WA, HARDT J, SCHRECKENBERGER M, EGLE UT, BARTENSTEIN P. Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 2003;74:922-8.
48. CLEARE AJ, MESSA C, RABBINER EA, GRASBY PM. Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635. Biol Psychiatry 2005;57:239-46.
49. YAMAMOTO S, OUCHI Y, ONOE H, et al. Reduction of serotonin transporters of patients with chronic fatigue syndrome. Neuroreport 2004;15:2571-4.
50. DELUCA J, JOHNSON SK, ELLIS SP, NATELSON BH. Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease. J Neurol Neurosurg Psychiatry 1997;62:151-5.
51. MICHIELS V, CLUYDTS R. Neuropsychological functioning in chronic fatigue syndrome: a review. Acta Psychiatr Scand 2001;103:84- 93.
52. BLACKWOOD SK, MCHALE SM, POWER MJ, GOODWIN GM, Lawrie SM. Effects of exercise on cognitive and motor function in chronic fatigue syndrome and depression. J Neurol Neurosurg Psychiatry 1998;65:541-6.
53. FISCHLER B, CLUYDTS R, DEGUCHT V, KAUFMAN L, DEMEIRLEIR K. Generalized anxitey disorders in chronic fatigue syndrome. Acta Psychiatr Scand 1997;95:405- 13.
54. GARRALDA E, RANGEL L, LEVIN M, ROBERTS H, UKOUMUNNE O. Psychiatric adjustment in adolescents with a history of chronic fatigue syndrome. J Am Acad Child Adolesc Psychiatry 1999;38:1515-21.
55. THEORELL T, BLOMKVIST V, LINDH G, EVENGARD B. Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom Med 1999;61:304- 10.
56. WHITE C, SCHWEITZER R. The role of personality in the development and perpetuation of chronic fatigue syndrome. J Psychosom Res 2000;48:515-24.
57. HUIBERS MJ, BLEIJENBERG G, VAN AMELSVOORT LG, et al. Predictors of outcome in fatigued employees on sick leave: results from a randomised trial. J Psychosom Res 2004;57:443-9.
58. NIJS J, DE MEIRLEIR K, DUQUET W. Kinesiophobia in chronic fatigue syndrome: assessment and associations with disability. Arch Phys Med Rehabil 2004;85:1586-92.
59. METZEGER FA, DENNEY DR. Perception of cognitive performance in patients with chronic fatigue syndrome. Ann Behav Med 2002;24:106-12.
60. BALL N, BUCHWALD DS, SCHMIDT D, GOLDBERG J, ASHTON S, ARMITAGE R. Monozygotic twins discordant for chronic fatigue syndrome: objective measures of sleep. J Psychosom Res 2004;56:207-12.
61. PRINS JB, BOS E, HUIBERS MJ, et al. Social support and the persistence of complaints in chronic fatigue syndrome. Psychother Psychosom 2004;73:174-82.
62. CLEARE AJ. The neuroendocrinology of chronic fatigue syndrome. Endocrine reviews 2003;24:236-52.
63. TIMMERS HJ, WIELING W, SOETEKOUW PM, BLEIJENBERG G, VAN DER MEER JW, LENDERS JW. Hemodynamic and neurohumoral responses to head-up tilt in patients with chronic fatigue syndrome. Clin Auton Res 2002;12:273-80.
64. KAVELAARS A, KUIS W, KNOOK L, SINNEMA G, HEIJNEN CJ. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000;85:692-6.
65. BOU-HOLAIGAH I, ROWE PC, KAN JS, CALKINS H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995;274:961-7.
66. ROWE PC, BOU-HOLAIGAH I, KAN JS, CALKINS H. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet 1995;345:623-4.
67. PECKERMAN A, LAMANCA JJ, DAHL KA, CHEMITIGANTI R, QUREISHI B, NATELSON B. Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Am J Med Sci 2003;326:55-60.
68. LAMANCA JJ, PECKERMAN A, WALKER J, et al. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 1999;19:107-10.
69. WYLLER VB, DUE R, SAUL JP, AMLIE JP, THAULOW E. Usefulness of an abnormal cardiovascular response during low-grade head-up tilt-test for discriminating adolescents with chronic fatigue from healthy controls. Am J Cardiol 2007 (in press).
70. STEWART J. Autonomic nervous dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res 2000;48:218-26.
71. TANAKA H, MATSUSHIMA R, TAMAI H, KAJIMOTO Y. Impaired postural cerebral hemodynamics in young patients with chronic fatigue with and without orthostatic intolerance. J Pediatr 2002;140:412-7.
72. MCCULLY KK, SMITH S, RAJAEI S, LEIGH JS, NATELSON BH. Muscle metabolism with blood flow restriction in chronic fatigue syndrome. J Appl Physiol 2004;96:871-8.
73. KAHN F, SPENCE V, KENNEDY G, BELCH JJF. Prolonged acetylcholine-induced vasodilation in the peripheral microcirculation of patients with chronic fatigue syndrome. Clin Physiol Funct Imaging 2003;23:282-5.
74. WHITING P, BAGNALL AM, SOWDEN AJ, CORNELL JE, MULROW CD, RAMIREZ G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 2001;286:1360-8.
75. STULEMEIJER M, DE JONG LW, FISELIER TJ, HOOGVELD SW, BLEIJENBERG G. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. BMJ 2005;330:14.
76. CAIRNS R, HOTOPF M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med 2005;55:20-31.
77. ROWE KS. Five-year follow-up of young people with chronic fatigue syndrome following the double-blind randomised controlled intravenous gammaglobulin trial. J Chronic Fatigue Syndr 1999;5:97-107.